MCID: DRG026
MIFTS: 51

Drug Reaction with Eosinophilia and Systemic Symptoms

Categories: Blood diseases, Immune diseases, Rare diseases, Skin diseases

Aliases & Classifications for Drug Reaction with Eosinophilia and Systemic Symptoms

MalaCards integrated aliases for Drug Reaction with Eosinophilia and Systemic Symptoms:

Name: Drug Reaction with Eosinophilia and Systemic Symptoms 54
Drug Rash with Eosinophilia and Systemic Symptoms 54 60
Drug Reaction Eosinophilic Systemic Syndrome 54 60
Dress Syndrome 54 60

Characteristics:

Orphanet epidemiological data:

60
drug rash with eosinophilia and systemic symptoms
Inheritance: Not applicable; Age of onset: All ages;

Classifications:



Summaries for Drug Reaction with Eosinophilia and Systemic Symptoms

NIH Rare Diseases : 54 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 139402Disease definitionDRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) is a hypersensitivity reaction characterized by a generalized skin rash, fever, eosinophilia, lymphocytosis and visceral involvement (hepatitis, nephritis, pneumonitis, pericarditis and myocarditis) and, in some patients, reactivation of human herpes virus 6.EpidemiologyPrevalence is unknown.EtiologyOnset usually occurs 2-6 weeks after administration of the causal medication. DRESS syndrome is most frequently associated with anticonvulsants and sulfonamides but other medications (allopurinol, cyclosporine, azathioprine, gold salts and antiviral agents) have also been implicated. The manifestations may persist for several weeks after withdrawal of the causative medication.Visit the Orphanet disease page for more resources.

MalaCards based summary : Drug Reaction with Eosinophilia and Systemic Symptoms, also known as drug rash with eosinophilia and systemic symptoms, is related to severe cutaneous adverse reaction and myocarditis. An important gene associated with Drug Reaction with Eosinophilia and Systemic Symptoms is HLA-B (Major Histocompatibility Complex, Class I, B), and among its related pathways/superpathways are Apoptosis and survival Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway and Downstream signaling in naive CD8+ T cells. The drugs Dapsone and leucovorin have been mentioned in the context of this disorder. Affiliated tissues include skin, liver and thyroid, and related phenotypes are encephalitis and fever

Wikipedia : 77 Drug reaction with eosinophilia and systemic symptoms (DRESS), also termed drug-induced hypersensitivity... more...

Related Diseases for Drug Reaction with Eosinophilia and Systemic Symptoms

Diseases related to Drug Reaction with Eosinophilia and Systemic Symptoms via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 213, show less)
# Related Disease Score Top Affiliating Genes
1 severe cutaneous adverse reaction 30.6 HLA-B TNF
2 myocarditis 30.5 HLA-B TNF
3 exanthem 30.5 CRP TNF
4 intermediate uveitis 30.2 HLA-B TNF
5 uveitis 30.2 HLA-B TNF
6 graft-versus-host disease 30.2 HLA-B TNF
7 pneumonia 30.1 CRP TNF
8 adult-onset still's disease 30.1 CRP TNF
9 familial mediterranean fever 30.1 CRP TNF
10 kawasaki disease 30.0 CRP TNF
11 diabetes mellitus 29.7 CRP HLA-B TNF
12 panuveitis 29.7 HLA-B TNF
13 cytomegalovirus infection 29.7 HLA-B TNF
14 endocarditis 29.6 CRP TNF
15 rheumatoid arthritis 29.6 CRP HLA-B TNF
16 brucellosis 29.6 CRP TNF
17 vasculitis 29.6 CRP HLA-B TNF
18 purpura 29.6 CRP TNF
19 juvenile rheumatoid arthritis 29.6 CRP TNF
20 hypereosinophilic syndrome 11.2
21 allergic hypersensitivity disease 10.7
22 hepatitis 10.4
23 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 10.3
24 vitiligo-associated multiple autoimmune disease susceptibility 1 10.2
25 alopecia 10.2
26 erythema multiforme 10.2
27 interstitial nephritis 10.2
28 stevens-johnson syndrome/toxic epidermal necrolysis 10.2
29 spondyloarthropathy 10.2 HLA-B TNF
30 nontuberculous mycobacterial lung disease 10.2 HLA-B TNF
31 cytomegalovirus retinitis 10.1 HLA-B TNF
32 alveolar echinococcosis 10.1 HLA-B TNF
33 echinococcosis 10.1 HLA-B TNF
34 indeterminate leprosy 10.1 HLA-B TNF
35 hematopoietic stem cell transplantation 10.1 HLA-B TNF
36 glaucomatocyclitic crisis 10.1 HLA-B TNF
37 geographic tongue 10.1 HLA-B TNF
38 complex regional pain syndrome 10.1 HLA-B TNF
39 aphthous stomatitis 10.1 HLA-B TNF
40 rheumatic heart disease 10.1 HLA-B TNF
41 uveal disease 10.1 HLA-B TNF
42 dengue hemorrhagic fever 10.1 HLA-B TNF
43 sclerosing cholangitis 10.1 HLA-B TNF
44 arthropathy 10.1 CRP TNF
45 salpingitis 10.1 CRP TNF
46 relapsing fever 10.1 CRP TNF
47 central nervous system vasculitis 10.1 CRP TNF
48 louse-borne relapsing fever 10.1 CRP TNF
49 rubella 10.1 HLA-B TNF
50 streptococcal meningitis 10.1 CRP TNF
51 meningitis 10.1 CRP TNF
52 tuberculous peritonitis 10.1 CRP TNF
53 peritonitis 10.1 CRP TNF
54 ischemic heart disease 10.1 CRP TNF
55 diverticulitis 10.1 CRP TNF
56 mycoplasma pneumoniae pneumonia 10.1 CRP TNF
57 hypersensitivity reaction type iii disease 10.1 CRP TNF
58 scrub typhus 10.1 CRP TNF
59 proctitis 10.1 CRP TNF
60 apnea, obstructive sleep 10.1 CRP TNF
61 bacterial sepsis 10.1 CRP TNF
62 suppurative cholangitis 10.1 CRP TNF
63 perinatal necrotizing enterocolitis 10.1 CRP TNF
64 palindromic rheumatism 10.1 CRP TNF
65 infective endocarditis 10.1 CRP TNF
66 extrinsic cardiomyopathy 10.1 CRP TNF
67 pleural disease 10.1 CRP TNF
68 lymph node disease 10.1 CRP TNF
69 pleurisy 10.1 CRP TNF
70 glomerulonephritis 10.1
71 acute kidney tubular necrosis 10.1
72 agammaglobulinemia 10.1
73 dermatitis 10.1
74 pancreatitis 10.1
75 exfoliative dermatitis 10.1
76 pyelonephritis 10.1 CRP TNF
77 leptospirosis 10.1 CRP TNF
78 lymphatic system disease 10.1 CRP TNF
79 pericarditis 10.1 CRP TNF
80 appendicitis 10.1 CRP TNF
81 temporal arteritis 10.1 CRP TNF
82 typhoid fever 10.1 CRP TNF
83 severe acute respiratory syndrome 10.1 CRP TNF
84 carotid stenosis 10.1 CRP TNF
85 acquired immunodeficiency syndrome 10.1 HLA-B TNF
86 obstructive jaundice 10.1 CRP TNF
87 autoimmune disease of musculoskeletal system 10.1 CRP TNF
88 pulmonary edema 10.1 CRP TNF
89 lyme disease 10.1 CRP TNF
90 bacterial meningitis 10.0 CRP TNF
91 chorioamnionitis 10.0 CRP TNF
92 pancreas disease 10.0 CRP TNF
93 primary bacterial infectious disease 10.0 CRP TNF
94 bacterial infectious disease 10.0 CRP TNF
95 gastroenteritis 10.0 CRP TNF
96 cystitis 10.0 CRP TNF
97 bone inflammation disease 10.0 CRP TNF
98 chlamydia 10.0 CRP TNF
99 sleep apnea 10.0 CRP TNF
100 end stage renal failure 10.0 CRP TNF
101 bronchiolitis 10.0 CRP TNF
102 bronchitis 10.0 CRP TNF
103 multiple sclerosis 10.0
104 myositis 10.0
105 alopecia universalis congenita 10.0
106 lung cancer 10.0
107 enterocolitis 10.0
108 sjogren syndrome 10.0
109 graves disease 1 10.0
110 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.0
111 basal cell carcinoma 1 10.0
112 dermatofibrosarcoma protuberans 10.0
113 infantile liver failure syndrome 1 10.0
114 acute liver failure 10.0
115 arthritis 10.0
116 hemophagocytic lymphohistiocytosis 10.0
117 leukemia 10.0
118 systemic scleroderma 10.0
119 lymphoma 10.0
120 angioimmunoblastic t-cell lymphoma 10.0
121 sialadenitis 10.0
122 vogt-koyanagi-harada disease 10.0
123 hepatitis a 10.0
124 toxic shock syndrome 10.0
125 urticaria 10.0
126 lymphadenitis 10.0
127 epilepsy 10.0
128 melanoma 10.0
129 cholecystitis 10.0
130 post-traumatic stress disorder 10.0
131 basal cell carcinoma 10.0
132 acalculous cholecystitis 10.0
133 folliculitis 10.0
134 human immunodeficiency virus infectious disease 10.0
135 conjunctivitis 10.0
136 thyroiditis 10.0
137 hyperthyroidism 10.0
138 herpes simplex 10.0
139 myeloid leukemia 10.0
140 leishmaniasis 10.0
141 pompholyx 10.0
142 alopecia areata 10.0
143 acute posterior multifocal placoid pigment epitheliopathy 10.0
144 eosinophilic pustular folliculitis 10.0
145 granulocytopenia 10.0
146 dysphagia 10.0
147 encephalopathy 10.0
148 cutaneous pseudolymphoma 10.0
149 overnutrition 10.0 CRP TNF
150 arteries, anomalies of 10.0 CRP TNF
151 glucose metabolism disease 10.0 CRP TNF
152 synovitis 10.0 CRP TNF
153 proteasome-associated autoinflammatory syndrome 1 10.0 CRP TNF
154 urinary system disease 10.0 CRP TNF
155 intestinal disease 10.0 CRP TNF
156 acquired metabolic disease 10.0 CRP TNF
157 periodontitis 10.0 CRP TNF
158 acute graft versus host disease 10.0 TNF TNFRSF4
159 mouth disease 10.0 CRP TNF
160 respiratory system disease 9.9 CRP TNF
161 tropical spastic paraparesis 9.9 HLA-B TNFRSF4
162 atherosclerosis susceptibility 9.9 CRP TNF
163 respiratory failure 9.9 CRP TNF
164 periodontal disease 9.9 CRP TNF
165 gastrointestinal system disease 9.9 CRP TNF
166 crohn's disease 9.9 CRP TNF
167 cerebrovascular disease 9.9 CRP TNF
168 nervous system disease 9.9 CRP TNF
169 autoimmune hepatitis 9.8
170 hepatitis c 9.8
171 hemorrhagic fever with renal syndrome 9.8 CRP HLA-B TNF
172 reactive arthritis 9.8 CRP HLA-B TNF
173 spondyloarthropathy 1 9.8 CRP HLA-B TNF
174 takayasu arteritis 9.8 CRP HLA-B TNF
175 spondylitis 9.8 CRP HLA-B TNF
176 cholangitis 9.8 CRP HLA-B TNF
177 rheumatic disease 9.8 CRP HLA-B TNF
178 psoriatic arthritis 9.8 CRP HLA-B TNF
179 behcet syndrome 9.8 CRP HLA-B TNF
180 ulcerative colitis 9.8 CRP TNF
181 maturity-onset diabetes of the young, type 1 9.7 CRP TNF
182 malaria 9.7 CRP HLA-B TNF
183 cardiac conduction defect 9.7
184 noonan syndrome 1 9.7
185 ascites, chylous 9.7
186 cystic fibrosis 9.7
187 hepatitis c virus 9.7
188 bipolar disorder 9.7
189 chronic kidney failure 9.7
190 liver cirrhosis 9.7
191 cardiac arrest 9.7
192 thrombosis 9.7
193 osteomyelitis 9.7
194 hepatic coma 9.7
195 hepatic encephalopathy 9.7
196 mental depression 9.7
197 erdheim-chester disease 9.7
198 kidney disease 9.7
199 peripheral nervous system disease 9.7
200 neuropathy 9.7
201 chorioretinitis 9.7
202 encephalitis 9.7
203 acute respiratory distress syndrome 9.7
204 autoimmune enteropathy 9.7
205 limbic encephalitis 9.7
206 lipogranulomatosis 9.7
207 pseudo-turner syndrome 9.7
208 syndrome of inappropriate antidiuretic hormone 9.7
209 depression 9.7
210 acute generalized exanthematous pustulosis 9.7
211 diffuse alveolar hemorrhage 9.7
212 pulmonary disease, chronic obstructive 9.6 CRP TNF
213 systemic lupus erythematosus 9.4 CRP TNF TNFRSF4

Graphical network of the top 20 diseases related to Drug Reaction with Eosinophilia and Systemic Symptoms:



Diseases related to Drug Reaction with Eosinophilia and Systemic Symptoms

Symptoms & Phenotypes for Drug Reaction with Eosinophilia and Systemic Symptoms

Human phenotypes related to Drug Reaction with Eosinophilia and Systemic Symptoms:

60 33 (showing 28, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 encephalitis 60 33 hallmark (90%) Very frequent (99-80%) HP:0002383
2 fever 60 33 hallmark (90%) Very frequent (99-80%) HP:0001945
3 weight loss 60 33 hallmark (90%) Very frequent (99-80%) HP:0001824
4 thyroiditis 60 33 hallmark (90%) Very frequent (99-80%) HP:0100646
5 erythema 60 33 hallmark (90%) Very frequent (99-80%) HP:0010783
6 macule 60 33 hallmark (90%) Very frequent (99-80%) HP:0012733
7 skin rash 60 33 hallmark (90%) Very frequent (99-80%) HP:0000988
8 lymphadenopathy 60 33 hallmark (90%) Very frequent (99-80%) HP:0002716
9 erythroderma 60 33 hallmark (90%) Very frequent (99-80%) HP:0001019
10 cardiac arrest 60 33 hallmark (90%) Very frequent (99-80%) HP:0001695
11 immunologic hypersensitivity 60 33 hallmark (90%) Very frequent (99-80%) HP:0100326
12 angioedema 60 33 hallmark (90%) Very frequent (99-80%) HP:0100665
13 elevated hepatic transaminase 60 33 frequent (33%) Frequent (79-30%) HP:0002910
14 pulmonary infiltrates 60 33 frequent (33%) Frequent (79-30%) HP:0002113
15 interstitial pneumonitis 60 33 frequent (33%) Frequent (79-30%) HP:0006515
16 lymphocytosis 60 33 frequent (33%) Frequent (79-30%) HP:0100827
17 renal insufficiency 60 33 occasional (7.5%) Occasional (29-5%) HP:0000083
18 dyspnea 60 33 occasional (7.5%) Occasional (29-5%) HP:0002094
19 hepatitis 60 33 occasional (7.5%) Occasional (29-5%) HP:0012115
20 peripheral neuropathy 60 33 occasional (7.5%) Occasional (29-5%) HP:0009830
21 nephrotic syndrome 60 33 occasional (7.5%) Occasional (29-5%) HP:0000100
22 myocarditis 60 33 occasional (7.5%) Occasional (29-5%) HP:0012819
23 cough 60 33 occasional (7.5%) Occasional (29-5%) HP:0012735
24 acute hepatic failure 60 33 occasional (7.5%) Occasional (29-5%) HP:0006554
25 eosinophilia 60 33 occasional (7.5%) Occasional (29-5%) HP:0001880
26 tubulointerstitial nephritis 60 33 occasional (7.5%) Occasional (29-5%) HP:0001970
27 pustule 60 33 occasional (7.5%) Occasional (29-5%) HP:0200039
28 enanthema 60 33 occasional (7.5%) Occasional (29-5%) HP:0030249

Drugs & Therapeutics for Drug Reaction with Eosinophilia and Systemic Symptoms

Drugs for Drug Reaction with Eosinophilia and Systemic Symptoms (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 74, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dapsone Approved, Investigational Phase 4 80-08-0 2955
2
leucovorin Approved Phase 4 58-05-9 143 6006
3
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
4 Antimalarials Phase 4
5 Folic Acid Antagonists Phase 4
6 Vitamin B9 Phase 4
7 Antiparasitic Agents Phase 4
8 Antiprotozoal Agents Phase 4
9 Vitamin B Complex Phase 4
10 Anti-Infective Agents Phase 4
11 Folate Phase 4
12 Anti-Bacterial Agents Phase 4
13 Immunoglobulins Phase 3
14 Antibodies Phase 3
15
Alprazolam Approved, Illicit, Investigational Phase 1 28981-97-7 2118
16 Anti-Anxiety Agents Phase 1
17 GABA Modulators Phase 1
18 Neurotransmitter Agents Phase 1,Not Applicable
19 Hypnotics and Sedatives Phase 1
20 Psychotropic Drugs Phase 1,Not Applicable
21 Tranquilizing Agents Phase 1,Not Applicable
22 Central Nervous System Depressants Phase 1,Not Applicable
23 GABA Agents Phase 1,Not Applicable
24
Prednisone Approved, Vet_approved Not Applicable 53-03-2 5865
25
Clobetasol Approved, Experimental, Investigational Not Applicable 25122-46-7, 25122-41-2 5311051 32798
26
Allopurinol Approved Not Applicable 315-30-0 2094
27
Oxcarbazepine Approved Not Applicable 28721-07-5 34312
28
Carbamazepine Approved, Investigational Not Applicable 298-46-4 2554
29
Valproic Acid Approved, Investigational Not Applicable 99-66-1 3121
30
Eslicarbazepine acetate Approved Not Applicable 236395-14-5, 75970-99-9 123618
31
Lamotrigine Approved, Investigational Not Applicable 84057-84-1 3878
32
Benzocaine Approved, Investigational Not Applicable 1994-09-7, 94-09-7 2337
33
Prednisolone phosphate Approved, Vet_approved Not Applicable 302-25-0
34
tannic acid Approved Not Applicable 1401-55-4
35
Etanercept Approved, Investigational Not Applicable 185243-69-0
36
Prednisolone Approved, Vet_approved Not Applicable 50-24-8 5755
37
Methylprednisolone hemisuccinate Approved Not Applicable 2921-57-5
38
Methylprednisolone Approved, Vet_approved Not Applicable 83-43-2 6741
39
Calcium Approved, Nutraceutical Not Applicable 7440-70-2 271
40
Prednisolone hemisuccinate Experimental Not Applicable 2920-86-7
41 Dermatologic Agents Not Applicable
42 Hormones, Hormone Substitutes, and Hormone Antagonists Not Applicable
43 Hormones Not Applicable
44 Emollients Not Applicable
45 Antineoplastic Agents, Hormonal Not Applicable
46 glucocorticoids Not Applicable
47 Anti-Inflammatory Agents Not Applicable
48 Hormone Antagonists Not Applicable
49 Antioxidants Not Applicable
50 Free Radical Scavengers Not Applicable
51 Antimetabolites Not Applicable
52 Antirheumatic Agents Not Applicable
53 Protective Agents Not Applicable
54 Calcium, Dietary Not Applicable
55 Anticonvulsants Not Applicable
56 Peripheral Nervous System Agents Not Applicable
57 Analgesics Not Applicable
58 Analgesics, Non-Narcotic Not Applicable
59 Antimanic Agents Not Applicable
60 Diuretics, Potassium Sparing Not Applicable
61 Antipsychotic Agents Not Applicable
62 Sodium Channel Blockers Not Applicable
63 calcium channel blockers Not Applicable
64 Cytochrome P-450 CYP3A Inducers Not Applicable
65 Gastrointestinal Agents Not Applicable
66 Immunologic Factors Not Applicable
67 Antiemetics Not Applicable
68 Immunosuppressive Agents Not Applicable
69 Methylprednisolone Acetate Not Applicable
70 Anti-Inflammatory Agents, Non-Steroidal Not Applicable
71 Prednisolone acetate Not Applicable
72 Autonomic Agents Not Applicable
73 Neuroprotective Agents Not Applicable
74 Antibiotics, Antitubercular

Interventional clinical trials:

(showing 12, show less)
# Name Status NCT ID Phase Drugs
1 Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome Unknown status NCT02550080 Phase 4 Dapsone
2 Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) Terminated NCT00505648 Phase 3 Tegeline®
3 A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users Completed NCT03509285 Phase 1 Alprazolam Placebo;Cenobamate placebo;Alprazolam;Cenobamate
4 Comparison Between Corticosteroid and Topical Steroids in the DRESS Unknown status NCT01987076 Not Applicable Prednisone;Clobetasol
5 HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction Unknown status NCT03046914 Not Applicable
6 Immunological and Viral Parameters in Patients Receiving Anti-epileptic Drugs Completed NCT02556320 Not Applicable anti-epileptic drug
7 Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions Completed NCT01276314 Not Applicable anti- TNF-a;Prednisolone
8 T Cell Response in Hypersensitivity Syndrome Completed NCT00213447
9 Multiple Drug Hypersensitivity Syndrome Recruiting NCT03784482
10 Severe Cutaneous Adverse Reactions in Thailand Recruiting NCT02574988
11 An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine Acetate Recruiting NCT02520557
12 Survey Study for Velaglucerase Alfa (VPRIV) in Japan Recruiting NCT03625882

Search NIH Clinical Center for Drug Reaction with Eosinophilia and Systemic Symptoms

Genetic Tests for Drug Reaction with Eosinophilia and Systemic Symptoms

Anatomical Context for Drug Reaction with Eosinophilia and Systemic Symptoms

MalaCards organs/tissues related to Drug Reaction with Eosinophilia and Systemic Symptoms:

42
Skin, Liver, Thyroid, T Cells, Kidney, Testes, Heart

Publications for Drug Reaction with Eosinophilia and Systemic Symptoms

Articles related to Drug Reaction with Eosinophilia and Systemic Symptoms:

(showing 341, show less)
# Title Authors Year
1
A Case Report of Fulminant Type 1 Diabetes Mellitus Caused by Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Iodine-Induced Thyrotoxicosis. ( 30937841 )
2019
2
Predictors of disease severity in drug reaction with eosinophilia and systemic symptoms. ( 30058562 )
2019
3
Drug reaction with eosinophilia and systemic symptoms syndrome induced by combination of vemurafenib and cobimetinib in melanoma: A series of 11 cases. ( 30081108 )
2019
4
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module. ( 30176295 )
2019
5
Valaciclovir: a culprit drug for drug reaction with eosinophilia and systemic symptoms not to be neglected. Three cases. ( 30222854 )
2019
6
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. ( 30240780 )
2019
7
Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms. ( 30403959 )
2019
8
Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come? ( 30652265 )
2019
9
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs. ( 30663091 )
2019
10
Facial pustules due to drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: A case report. ( 30666704 )
2019
11
Comments on: Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms. ( 30685268 )
2019
12
Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome. ( 30735685 )
2019
13
Erythema Gyratum Repens as a Manifestation of Drug Reaction with Eosinophilia and Systemic Symptoms. ( 30745644 )
2019
14
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. ( 30776417 )
2019
15
Drug reaction with eosinophilia and systemic symptoms (DRESS) in children. ( 30830064 )
2019
16
Can we allow a further intake of drugs poorly suspected as responsible in responsible in drug reaction with eosinophilia and systemic symptoms (DRESS)? A study of practice. ( 30834582 )
2019
17
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome associated with Ethambutol use: A Case Report. ( 30848209 )
2019
18
Drug reaction with eosinophilia and systemic symptoms presenting as leukoencephalopathy. ( 30868617 )
2019
19
A Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Clobazam. ( 30870346 )
2019
20
Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). ( 30877266 )
2019
21
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS Syndrome). ( 30879852 )
2019
22
Drug reaction with eosinophilia and systemic symptoms in a cohort of Asian children. ( 30920020 )
2019
23
Pazopanib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Case Report. ( 30946042 )
2019
24
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. ( 31000444 )
2019
25
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculous drugs: two case reports and a review of the literature. ( 31021423 )
2019
26
Drug reaction with eosinophilia and systemic symptoms in pediatric patients: A clinicopathological study of 16 cases in the National Center of Pharmacovigilance of Tunisia. ( 31023620 )
2019
27
Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Masquerading as Elusive Sepsis. ( 31093389 )
2019
28
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by imatinib. ( 30706827 )
2019
29
Drug Rash With Eosinophilia and Systemic Symptoms: Captopril, an Unusual Culprit Drug. ( 31045940 )
2019
30
Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo. ( 30578426 )
2018
31
Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS) caused by levofloxacin in a patient with systemic scleroderma, rheumatoid arthritis, and Sjogren syndrome. ( 30484869 )
2018
32
Refractory cardiac myocarditis associated with drug rash with eosinophilia and systemic symptoms syndrome due to anti-bipolar disorder drugs: a case report. ( 31020177 )
2018
33
Imatinib-induced drug reaction with eosinophilia and systemic symptoms in solid tumors: a patient with dermatofibrosarcoma protuberans and successful desensitization management. ( 30096127 )
2018
34
Use of antiviral medications in drug reaction with eosinophilia and systemic symptoms (DRESS): A case of infantile DRESS. ( 29334124 )
2018
35
Lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) during primary Epstein-Barr virus (EBV) infection. ( 29367368 )
2018
36
Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab. ( 29384118 )
2018
37
Drug Reaction with Eosinophilia and Systemic Symptoms Associated with Reactivation of Epstein-Barr Virus and/or Cytomegalovirus Leading to Hemophagocytic Syndrome in One of Two Patients. ( 29386835 )
2018
38
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: Case report of severe multiorgan involvement to perindopril/amlodipine combination antihypertensive. ( 29387775 )
2018
39
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature. ( 29440628 )
2018
40
Dapsone-induced drug reaction with eosinophilia and systemic symptoms associated with HLA-B*13:01. ( 29512326 )
2018
41
Overexpression of cytotoxic proteins correlates with liver function impairment in patients with drug reaction with eosinophilia and systemic symptoms (DRESS). ( 29521632 )
2018
42
Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature. ( 29527023 )
2018
43
Up-regulation of Human Herpesvirus 6B-derived microRNAs in the Serum of Patients with Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. ( 29542806 )
2018
44
Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms. ( 29568844 )
2018
45
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome due to ethambutol. ( 29602678 )
2018
46
Drug reaction with eosinophilia and systemic symptoms syndrome induced by benznidazole. ( 29635801 )
2018
47
C-Reactive Protein and Procalcitonin in Case Reports of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. ( 29656292 )
2018
48
Drug reaction with eosinophilia and systemic symptoms: DRESS syndrome. ( 29687681 )
2018
49
Classic autoimmune type 1 diabetes mellitus after a case of drug reaction with eosinophilia and systemic symptoms (DRESS). ( 29693052 )
2018
50
Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. ( 29744372 )
2018
51
Author's reply: Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms. ( 29796687 )
2018
52
Comment on: Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms. ( 29799057 )
2018
53
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy. ( 29934423 )
2018
54
Drug reaction with eosinophilia and systemic symptoms caused by spironolactone: Case report. ( 30009386 )
2018
55
Ivermectin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. ( 30023418 )
2018
56
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS. ( 30027105 )
2018
57
A Rare Case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Glimepiride, the Unlikely Culprit. ( 30069245 )
2018
58
Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement. ( 30099742 )
2018
59
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis. ( 30111350 )
2018
60
Myocarditis Associated with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report and Review of the Literature. ( 30122752 )
2018
61
Drug reaction with eosinophilia and systemic symptoms (DRESS) and multiple organ dysfunction syndrome (MODS): one more reason for a new effective treatment against leishmaniasis. ( 30156263 )
2018
62
Reticular rash in drug reaction with eosinophilia and systemic symptoms syndrome: A clue to parvovirus B19 reactivation? ( 30167447 )
2018
63
Trimethoprim-sulfamethoxazole-induced drug reaction with eosinophilia and systemic symptoms in a child with congenital renal disease. ( 30187970 )
2018
64
Reverse Isotopic Phenomenon in Drug Reaction with Eosinophilia and Systemic Symptoms. ( 30236950 )
2018
65
Case of drug reaction with eosinophilia and systemic symptoms secondary to vancomycin. ( 30301733 )
2018
66
A case of Vogt-Koyanagi-Harada disease as a sequela of drug reaction with eosinophilia and systemic symptoms. ( 30306111 )
2018
67
Successful treatment of drug reaction with eosinophilia and systemic symptoms syndrome relapse with oral pulsed dexamethasone. ( 30364766 )
2018
68
Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome. ( 30368475 )
2018
69
Cyclosporine treatment of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report and brief review of the literature. ( 30574026 )
2018
70
Valproate-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). ( 30581223 )
2018
71
A familial mediterranean fever flare induced by a drug reaction with eosinophilia and systemic symptoms. ( 28653374 )
2018
72
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome successfully treated with mepolizumab. ( 29133221 )
2018
73
Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome. ( 29150836 )
2018
74
Clinical, Viral and Genetic Characteristics of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Shanghai, China. ( 29242946 )
2018
75
Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment. ( 29265576 )
2018
76
Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Presenting After the Initiation of Staphylococcus hominis Infectious Endocarditis Treatment: A Case Report and Updated Review of Management Considerations. ( 30761231 )
2018
77
Diclofenac induced drug rash with eosinophilia and systemic symptoms. ( 30055779 )
2018
78
Allopurinol-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Cause of Acalculous Cholecystitis? ( 29057181 )
2017
79
Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors. ( 28207633 )
2017
80
Acute Posterior Multifocal Placoid Pigment Epitheliopathy Associated With Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. ( 28056129 )
2017
81
Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome). ( 28611626 )
2017
82
Drug reaction with eosinophilia and systemic symptoms in metastatic basal cell carcinoma treated with vismodegib. ( 28195319 )
2017
83
A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms. ( 29432504 )
2017
84
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report. ( 29629004 )
2017
85
Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients. ( 30148271 )
2017
86
Drug-specific CD4+ T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome. ( 27373553 )
2017
87
Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia. ( 27389710 )
2017
88
HLA B62 as a possible risk factor for drug reaction with eosinophilia and systemic symptoms to piperacillin/tazobactam. ( 27914818 )
2017
89
Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: An immunohistochemical study. ( 27923648 )
2017
90
Reversible Vegetative State in a Child Due to Drug Reaction with Eosinophilia and Systemic Symptoms. ( 27924464 )
2017
91
Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management. ( 27936971 )
2017
92
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Teicoplanin: A Case Report. ( 28000142 )
2017
93
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist. ( 28138822 )
2017
94
A new case of imatinib-induced drug reaction with eosinophilia and systemic symptoms. ( 28164890 )
2017
95
Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico. ( 28225953 )
2017
96
Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. ( 28369189 )
2017
97
Drug Reaction with Eosinophilia and Systemic Symptoms: Retrospective Analysis of 104 Cases over One Decade. ( 28397724 )
2017
98
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in Children: A Case Report. ( 28398207 )
2017
99
Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome. ( 28433575 )
2017
100
Virus Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Results from a Strong Drug-Specific Immune Response. ( 28483323 )
2017
101
Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease. ( 28531906 )
2017
102
Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report. ( 28556959 )
2017
103
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. ( 28598363 )
2017
104
Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS). ( 28633581 )
2017
105
DRESS Syndrome: Drug Reaction With Eosinophilia and Systemic Symptoms. ( 28665896 )
2017
106
Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea. ( 28718873 )
2017
107
Two Catastrophes in One Patient: Drug Reaction with Eosinophilia and Systemic Symptoms and Toxic Shock Syndrome. ( 28721327 )
2017
108
Drug reaction with eosinophilia and systemic symptoms (DRESS) successfully treated with tumor necrosis factor-α inhibitor. ( 28752124 )
2017
109
Neosensitization to Multiple Drugs Following Valproate-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome. ( 28845181 )
2017
110
Vancomycin-associated drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: masquerading under the guise of sepsis. ( 29054953 )
2017
111
Herpes simplex virus reactivation: is it common or rare in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? ( 29165299 )
2017
112
How to identify DRESS, drug reaction with eosinophilia and systemic symptoms? ( 29199808 )
2017
113
New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology. ( 29255708 )
2017
114
Highly Probable Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Lenalidomide. ( 29276264 )
2017
115
Drug reaction with eosinophilia and systemic symptoms in a child on multiple antiepileptics. ( 29276875 )
2017
116
Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic. ( 28008656 )
2017
117
Skin-Homing IL-13-Producing T Cells Expand in the Circulation of Patients with Drug Rash with Eosinophilia and Systemic Symptoms. ( 28601883 )
2017
118
Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin. ( 28830901 )
2017
119
Letter to the editor "Drug rash with eosinophilia and systemic symptoms syndrome induced by carbamazepine: Case report". ( 29083557 )
2017
120
Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib. ( 29296640 )
2017
121
Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome. ( 27017438 )
2017
122
Alopecia Areata and Vitiligo as a Long-term Sequelae of Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome. ( 27057057 )
2016
123
Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome. ( 27078005 )
2016
124
Unusual Endoscopic Features in a Child With Drug Reaction With Eosinophilia and Systemic Symptoms. ( 25493343 )
2016
125
Drug reaction with eosinophilia and systemic symptoms: a clinicopathological study of six cases at a teaching hospital in midwestern Brazil. ( 26329991 )
2016
126
Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. ( 26412450 )
2016
127
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient. ( 26597350 )
2016
128
Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis. ( 26728807 )
2016
129
Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin. ( 26985439 )
2016
130
Drug Reaction with Eosinophilia and Systemic Symptoms in Children: A Prospective Study. ( 27001334 )
2016
131
Severe Agranulocytosis in Two Patients with Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms. ( 27025798 )
2016
132
Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database. ( 27060861 )
2016
133
Peripheral blood mononuclear cell gene expression testing and the heterogeneity of T-cell-mediated drug reaction with eosinophilia and systemic symptoms syndrome. ( 27067458 )
2016
134
Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms. ( 27087170 )
2016
135
Drug reaction with eosinophilia and systemic symptoms due to lercanidipine. ( 27088943 )
2016
136
Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. ( 27128886 )
2016
137
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand. ( 27134114 )
2016
138
Rivaroxaban-Induced Drug Reaction With Eosinophilia and Systemic Symptoms. ( 27164633 )
2016
139
Preferential expression of CD134, an HHV-6 cellular receptor, on CD4T cells in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS). ( 27174092 )
2016
140
Co-existence of histopathological features is characteristic in drug reaction with eosinophilia and systemic symptoms and correlates with high grades of cutaneous abnormalities. ( 27225695 )
2016
141
Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome). ( 27310545 )
2016
142
Probable Griseofulvin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms in a Child. ( 27397873 )
2016
143
Fulminating Course of Drug Reaction with Eosinophilia and Systemic Symptoms exacerbated by a Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis overlap. ( 27430091 )
2016
144
Sulthiame-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. ( 27524391 )
2016
145
Griseofulvin associated with drug reaction with eosinophilia and systemic symptoms (DRESS). ( 27556061 )
2016
146
Drug Reaction with Eosinophilia and Systemic Symptoms or Virus Reactivation with Eosinophilia and Systemic Symptoms. ( 27595878 )
2016
147
Drug Reaction with Eosinophilia and Systemic Symptoms or Herpes Virus Infection: Author's Reply. ( 27882668 )
2016
148
Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child. ( 28073704 )
2016
149
Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report. ( 28144463 )
2016
150
Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. ( 27181555 )
2016
151
Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis. ( 27651712 )
2016
152
Acute tubular necrosis as a part of vancomycin induced drug rash with eosinophilia and systemic symptoms syndrome with coincident postinfectious glomerulonephritis. ( 27186222 )
2016
153
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) induced by antituberculous treatment. ( 28994898 )
2016
154
Reactivation of Skin Lesions After Patch Testing to Investigate Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome. ( 27340118 )
2016
155
Cefotaxime-induced drug rash with eosinophilia and systemic symptoms syndrome in a 7-year-old boy. ( 27364942 )
2016
156
Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS/DRESS). ( 27374681 )
2016
157
Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane. ( 26298826 )
2016
158
Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised. ( 24388810 )
2015
159
Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients. ( 24738653 )
2015
160
Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection. ( 25074626 )
2015
161
Post-traumatic stress disorder following drug reaction with eosinophilia and systemic symptoms. ( 25154661 )
2015
162
Erythema multiforme-like drug reaction with eosinophilia and systemic symptoms (DRESS). ( 25545118 )
2015
163
Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities. ( 25547780 )
2015
164
Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). ( 25623158 )
2015
165
Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction. ( 25756365 )
2015
166
Lamotrigine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). ( 26055594 )
2015
167
Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients. ( 26271788 )
2015
168
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases. ( 26354734 )
2015
169
Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS). ( 26365588 )
2015
170
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A National Analysis of Data from 10-Year Post-marketing Surveillance. ( 26370105 )
2015
171
US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone. ( 26455682 )
2015
172
Drug reaction with eosinophilia and systemic symptoms syndrome. ( 26534757 )
2015
173
Drug reaction with eosinophilia and systemic symptoms without skin rash. ( 26729967 )
2015
174
Isoniazid-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Presenting as Acute Eosinophilic Myocarditis. ( 25986261 )
2015
175
Myocarditis in drug rash with eosinophilia and systemic symptoms. ( 25234569 )
2015
176
DRESS Syndrome: Drug Rash with Eosinophilia and Systemic Symptoms. ( 26591154 )
2015
177
Drug Rash with Eosinophilia and Systemic Symptoms to antituberculosis treatment. ( 26895118 )
2015
178
A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infection. ( 25239077 )
2015
179
Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. ( 25630796 )
2015
180
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with histologic features mimicking cutaneous pseudolymphoma. ( 25156337 )
2014
181
Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS). ( 24329105 )
2014
182
Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features. ( 24369386 )
2014
183
TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS). ( 24517870 )
2014
184
Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms. ( 24565781 )
2014
185
Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS). ( 24601914 )
2014
186
Encephalopathy and strokes secondary to drug reaction with eosinophilia and systemic symptoms: a case report. ( 24607054 )
2014
187
Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine. ( 24635066 )
2014
188
Drug reaction with eosinophilia and systemic symptoms associated with raltegravir use: case report and review of the literature. ( 24685746 )
2014
189
Omeprazole-induced drug reaction with eosinophilia and systemic symptoms (DRESS). ( 24751668 )
2014
190
Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV? ( 24773172 )
2014
191
Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation. ( 24819756 )
2014
192
Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution. ( 24823399 )
2014
193
Drug Reaction with Eosinophilia and Systemic Symptoms: DRESS following Initiation of Oxcarbazepine with Elevated Human Herpesvirus-6 Titer. ( 24826354 )
2014
194
Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome. ( 24843796 )
2014
195
The serum level of HMGB1 (high mobility group box 1 protein) is preferentially high in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. ( 24903194 )
2014
196
Severe enterocolitis associated with antiepileptic-induced drug reaction with eosinophilia and systemic symptoms. ( 24935058 )
2014
197
Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome. ( 25041771 )
2014
198
Evidence for human herpesvirus-6B infection of regulatory T-cells in acute systemic lymphadenitis in an immunocompetent adult with the drug reaction with eosinophilia and systemic symptoms syndrome: a case report. ( 25249343 )
2014
199
Suspicion of fenofibrate-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report. ( 25269143 )
2014
200
Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report. ( 25297051 )
2014
201
Retinal hemorrhages and intermediate uveitis in a patient with drug reaction with eosinophilia and systemic symptoms syndrome: a case report. ( 25372334 )
2014
202
Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS). ( 23461376 )
2014
203
Drug reaction with eosinophilia and systemic symptoms syndrome caused by an everolimus-eluting stent. ( 23967898 )
2014
204
A case of DRESS (drug reaction with eosinophilia and systemic symptoms) with acute interstitial nephritis secondary to lenalidomide. ( 23999760 )
2014
205
Ceftriaxone induced drug rash with eosinophilia and systemic symptoms. ( 25114941 )
2014
206
HLA-B*13:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population. ( 25303297 )
2014
207
Imatinib causing drug rash with eosinophilia and systemic symptoms: A rare cutaneous reaction. ( 25593801 )
2014
208
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome and hepatitis induced by phenytoin. ( 23829691 )
2014
209
Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man. ( 24450829 )
2014
210
Increased ratio of FoxP3+ regulatory T cells/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms. ( 24635062 )
2014
211
Drug rash with eosinophilia and systemic symptoms syndrome induced by chloral hydrate in early childhood. ( 24843805 )
2014
212
Liver transplantation in a child with acute liver failure resulting from drug rash with eosinophilia and systemic symptoms syndrome. ( 23741237 )
2013
213
Ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by hemophagocytic lymphohistiocytosis. ( 24565550 )
2013
214
Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications. ( 24569311 )
2013
215
Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department. ( 21852061 )
2013
216
Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. ( 22959230 )
2013
217
Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. ( 23034060 )
2013
218
Drug reaction with eosinophilia and systemic symptoms syndrome associated myocarditis: a survival experience after extracorporeal membrane oxygenation support. ( 23173909 )
2013
219
Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement. ( 23216243 )
2013
220
Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking phenytoin and levetiracetam: a case report. ( 23286229 )
2013
221
Atypical erythema multiforme is a prognostic indicator of severe hepatic dysfunction in Dress (Drug Reaction with Eosinophilia and Systemic Symptoms). ( 23362966 )
2013
222
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an atypical case during treatment with sulfasalazine. ( 23406887 )
2013
223
Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS). ( 23426332 )
2013
224
A case of drug reaction with eosinophilia and systemic symptoms induced by ethambutol with early features resembling Stevens-Johnson syndrome. ( 23584150 )
2013
225
Fulminant type 1 diabetes in the course of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome. ( 23613608 )
2013
226
Thyroid dysfunction in drug reaction with eosinophilia and systemic symptoms (DRESS): an unusual manifestation of systemic drug hypersensitivity. ( 23614562 )
2013
227
Drug reaction with eosinophilia and systemic symptoms and thyroiditis: human herpesvirus-6, the possible common link. ( 23725057 )
2013
228
Fever and exanthema in a young patient: drug reaction with eosinophilia and systemic symptoms due to allopurinol. ( 23726774 )
2013
229
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. ( 23855313 )
2013
230
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. ( 23882307 )
2013
231
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7). ( 23904426 )
2013
232
Raltegravir-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome - implications for clinical practice and patient safety. ( 23970584 )
2013
233
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) in an Adolescent Treated With Lamotrigine. ( 24052787 )
2013
234
Shock state: an unrecognized and underestimated presentation of drug reaction with eosinophilia and systemic symptoms. ( 24088996 )
2013
235
Diagnosis of DRESS (drug reaction with eosinophilia and systemic symptoms) in the intensive care unit: essential but challenging. ( 24135666 )
2013
236
Drug reaction with eosinophilia and systemic symptoms syndrome: a picture is worth a thousand words. ( 24238166 )
2013
237
Drug reaction with eosinophilia and systemic symptoms syndrome and toxic epidermal necrolysis: an uncommon confounding oral mucosal overlap. ( 24238167 )
2013
238
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and dysphagia: a noteworthy association. ( 24238169 )
2013
239
Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms syndrome. ( 24238171 )
2013
240
Reply to: "Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms". ( 24238172 )
2013
241
Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivation. ( 24016284 )
2013
242
A case of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) related to rufinamide. ( 24021364 )
2013
243
Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. ( 24133560 )
2013
244
Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Due to Anti-TB Medication. ( 24479051 )
2013
245
Cytokine gene expression profiling to help identify a safe antibiotic in a patient with drug rash with eosinophilia and systemic symptoms. ( 24565631 )
2013
246
Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS). ( 23141052 )
2013
247
Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate. ( 23361875 )
2013
248
Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbital. ( 23456403 )
2013
249
Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis. ( 22901319 )
2012
250
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect? ( 21792562 )
2012
251
Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms. ( 22002792 )
2012
252
Severe hypocalcemia and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome under deferasirox therapy for myelodysplasic syndrome. ( 22120845 )
2012
253
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms syndrome induced by cilostazol and carbamazepine. ( 22380544 )
2012
254
Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. ( 22714760 )
2012
255
Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome. ( 22764327 )
2012
256
Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug. ( 22840850 )
2012
257
A case of drug reaction with eosinophilia and systemic symptoms. ( 22966234 )
2012
258
Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis. ( 23062470 )
2012
259
Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. ( 23101424 )
2012
260
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. ( 23137713 )
2012
261
Drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient taking sitagliptin. ( 23183246 )
2012
262
Drug reaction with eosinophilia and systemic symptoms associated with H1N1 vaccination. ( 23253004 )
2012
263
Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report. ( 22511907 )
2012
264
The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. ( 22525393 )
2012
265
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). ( 22611746 )
2012
266
Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. ( 23165860 )
2012
267
Drug rash with eosinophilia and systemic symptoms (DRESS) probably induced by cefotaxime: a report of two cases. ( 21817121 )
2012
268
A case of drug rash with eosinophilia and systemic symptoms (DRESS) syndrome complicating airway management. ( 22271506 )
2012
269
Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. ( 21143513 )
2011
270
Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases. ( 21410659 )
2011
271
Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by cidofovir in a transplant recipient: a misunderstanding of DRESS. ( 21501355 )
2011
272
Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone. ( 21527371 )
2011
273
Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). ( 21697047 )
2011
274
Drug reaction with eosinophilia and systemic symptoms induced by carbamazepine: DRESSed to kill. ( 21762844 )
2011
275
Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr virus infection. ( 22010986 )
2011
276
Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant. ( 21217791 )
2011
277
Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin. ( 21219413 )
2011
278
Photodistribution of rash in phenytoin-induced drug rash with eosinophilia and systemic symptoms. ( 21418282 )
2011
279
Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS). ( 21951554 )
2011
280
Case of drug rash with eosinophilia and systemic symptoms induced by zonisamide and reactivation of human herpes virus 7. ( 21998830 )
2011
281
Allopurinol causing drug rash with eosinophilia and systemic symptoms syndrome: a challenging diagnosis. ( 22162933 )
2011
282
Drug rash with eosinophilia and systemic symptoms: two emergency department cases. ( 22224160 )
2011
283
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir. ( 20846239 )
2011
284
Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis. ( 19665822 )
2010
285
Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro. ( 19822481 )
2010
286
Drug reaction with eosinophilia and systemic symptoms. ( 19933788 )
2010
287
Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation. ( 20110143 )
2010
288
Bosentan-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. ( 20439535 )
2010
289
Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. ( 20713773 )
2010
290
Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. ( 20739682 )
2010
291
Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome with recurrence. ( 20929487 )
2010
292
Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and stevens-johnson syndrome. ( 20358026 )
2010
293
First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis. ( 21098750 )
2010
294
Antituberculosis drug-induced drug rash with eosinophilia and systemic symptoms syndrome confirmed by patch testing. ( 21314014 )
2010
295
Penicillin V-induced drug rash with eosinophilia and systemic symptoms. ( 21702250 )
2010
296
Drug rash with eosinophilia and systemic symptoms syndrome induced by sulfasalazine. ( 19854669 )
2010
297
Drug rash with eosinophilia and systemic symptoms (DRESS): changing carbamazepine to phenobarbital controlled epilepsy without the recurrence of DRESS. ( 20103499 )
2010
298
Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine. ( 20546480 )
2010
299
Hypersensitivity to amoxicillin after drug rash with eosinophilia and systemic symptoms (DRESS) to carbamazepine and allopurinol: a possible co-sensitization. ( 20653681 )
2010
300
Drug rash with eosinophilia and systemic symptoms due to telaprevir. ( 20798484 )
2010
301
Drug rash with eosinophilia and systemic symptoms syndrome associated with clindamycin. ( 20843501 )
2010
302
Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease. ( 19103366 )
2009
303
Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. ( 19153346 )
2009
304
Drug reaction with eosinophilia and systemic symptoms: a cause of human herpesvirus 6-related fulminant myocarditis and hepatitis in immunocompetent patients. ( 19762069 )
2009
305
Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. ( 19733945 )
2009
306
Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock. ( 19424074 )
2009
307
The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. ( 19563993 )
2009
308
Drug rash with eosinophilia and systemic symptoms after penicillin V administration in a patient with acquired C1 inhibitor acquired deficiency. ( 19639734 )
2009
309
Drug rash with eosinophilia and systemic symptoms and graft-versus-host disease developing sequentially in a patient. ( 18793307 )
2009
310
Drug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemia. ( 19122478 )
2009
311
Acute renal failure in a 3-year-old child as part of the drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome following hepatitis A. ( 18040726 )
2008
312
Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. ( 18717872 )
2008
313
Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). ( 18821094 )
2008
314
Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms syndrome in a 35-year-old man with epilepsy. ( 18836349 )
2008
315
Probable drug rash with eosinophilia and systemic symptoms syndrome related to tetrazepam. ( 18031497 )
2008
316
Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin. ( 18533962 )
2008
317
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. ( 18583892 )
2008
318
Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. ( 18627428 )
2008
319
Sulfasalazine-induced DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms). ( 18853032 )
2008
320
Drug rash with eosinophilia and systemic symptoms after ibuprofen intake. ( 17982931 )
2007
321
A recurrent drug rash with eosinophilia and systemic symptoms. ( 18035998 )
2007
322
Drug rash with eosinophilia and systemic symptoms syndrome due to quinine. ( 18097122 )
2007
323
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome: suspected association with titanium bioprosthesis. ( 17873538 )
2007
324
Drug rash with eosinophilia and systemic symptoms induced by lamotrigine therapy. ( 17880778 )
2007
325
Drug rash with eosinophilia and systemic symptoms syndrome: sex and the causative agent. ( 17975358 )
2007
326
Drug Rash with eosinophilia and systemic symptoms versus Stevens-Johnson Syndrome--a case that indicates a stumbling block in the current classification. ( 16940741 )
2006
327
Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen. ( 16710584 )
2006
328
Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). ( 17229608 )
2006
329
Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification. ( 15896547 )
2005
330
Possible drug rash with eosinophilia and systemic symptoms syndrome after exposure to epoetin alfa. ( 16303911 )
2005
331
Severe sialadenitis: a new complication of drug reaction with eosinophilia and systemic symptoms. ( 15523370 )
2004
332
Drug rash with eosinophilia and systemic symptoms (DRESS) due to streptomycin. ( 15040497 )
2004
333
Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus. ( 12738113 )
2003
334
Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. ( 12771485 )
2003
335
Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms. ( 12839588 )
2003
336
Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone. ( 12897635 )
2003
337
Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. ( 11255328 )
2001
338
Drug rash with eosinophilia and systemic symptoms caused by topical application of mercury. ( 11146363 )
2000
339
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). ( 10544509 )
1999
340
DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy. ( 9827291 )
1998
341
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). ( 9069593 )
1996

Variations for Drug Reaction with Eosinophilia and Systemic Symptoms

Expression for Drug Reaction with Eosinophilia and Systemic Symptoms

Search GEO for disease gene expression data for Drug Reaction with Eosinophilia and Systemic Symptoms.

Pathways for Drug Reaction with Eosinophilia and Systemic Symptoms

Pathways related to Drug Reaction with Eosinophilia and Systemic Symptoms according to GeneCards Suite gene sharing:

(showing 3, show less)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.02 TNF TNFRSF4
2
Show member pathways
10.74 TNF TNFRSF4
3 9.9 CRP TNF

GO Terms for Drug Reaction with Eosinophilia and Systemic Symptoms

Cellular components related to Drug Reaction with Eosinophilia and Systemic Symptoms according to GeneCards Suite gene sharing:

(showing 1, show less)
# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 8.8 HLA-B TNF TNFRSF4

Biological processes related to Drug Reaction with Eosinophilia and Systemic Symptoms according to GeneCards Suite gene sharing:

(showing 5, show less)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.33 HLA-B TNF TNFRSF4
2 defense response to Gram-positive bacterium GO:0050830 9.32 CRP TNF
3 tumor necrosis factor-mediated signaling pathway GO:0033209 9.26 TNF TNFRSF4
4 inflammatory response GO:0006954 9.13 CRP TNF TNFRSF4
5 negative regulation of lipid storage GO:0010888 8.62 CRP TNF

Sources for Drug Reaction with Eosinophilia and Systemic Symptoms

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....